#China #NASDAQ #Compliance #Changzhou #Jin Medical

Jin Medical International Ltd. Regains Nasdaq Compliance

Jin Medical International Ltd. (NASDAQ: ZJYL), a prominent player in the rehabilitation medical equipment sector, has officially announced that it has met the requirements set forth by Nasdaq regarding the minimum bid price. On April 7, 2026, the company received a formal notification from Nasdaq's Listing Qualifications Department confirming their renewed compliance with Rule 5550(a)(2). This rule mandates that a company's shares maintain a minimum closing bid price of $1.00 per share.

Over the past few weeks, Jin Medical’s Class A ordinary shares successfully maintained a bid price of over $1.00 for more than ten consecutive business days. This achievement is not just a financial milestone; it symbolizes the company’s enduring commitment to its operations and strategic goals.

Commitment to Core Operations

In light of this development, Jin Medical plans to continue concentrating on its core business operations as well as its strategic initiatives. Founded in 2006 and based in Changzhou, Jiangsu Province, China, Jin Medical has carved a niche in designing, developing, manufacturing, and marketing various medical aids, including wheelchairs and lifestyle support products for the disabled and elderly. With two operational manufacturing facilities aggregating approximately 230,000 square feet, it is now venturing into an expansive new facility in Chuzhou, Anhui Province, which will span 430,000 square feet.

Jin Medical has cultivated a solid distribution network, working with over 40 domestic distributors and more than 20 international distributors. Their wheelchair product range, which features over 30 innovative models, is particularly favored in markets such as Japan and China. The company prides itself on delivering lightweight and ergonomic wheelchair solutions that enhance the quality of life for users.

Strategic Reflections and Future Outlook

This compliance brings forth renewed optimism and reassurance to investors and stakeholders regarding Jin Medical's business trajectory. While the company has celebrated this achievement, it remains cognizant of the challenges that lie ahead. The management emphasizes a commitment to overcoming barriers and achieving excellence in their field.

Forward-looking statements made by the company express a commitment to growth and responsiveness to market needs. This includes a focus on research and development, alongside continued efforts to meet evolving consumer demands and heightened competition within the industry.

Investors are encouraged to remain engaged with Jin Medical as the company strives to enhance its market position and foster long-term growth strategies. The latest news and updates can be accessed on Jin Medical’s official website jinmed.com.

In conclusion, as Jin Medical International Ltd. regains its standing within the Nasdaq framework, it firmly re-establishes itself as a significant entity in the healthcare and rehabilitation equipment space, demonstrating resilience and a forward-thinking approach.